|
Comparative effectiveness trial of transoral head and neck surgery followed by adjuvant radio(chemo)therapy versus primary radiochemotherapy for oropharyngeal cancer (TopROC). |
|
|
No Relationships to Disclose |
|
|
Honoraria - AstraZeneca; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dome |
Consulting or Advisory Role - AstraZeneca; Merck Sharp & Dome |
|
|
No Relationships to Disclose |
|
|
Honoraria - Bristol-Myers Squibb; Merck Serono |
Consulting or Advisory Role - Bristol-Myers Squibb |
Travel, Accommodations, Expenses - Bristol-Myers Squibb |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Brainlab |
|
|
Honoraria - Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dome |
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dome |
Research Funding - Merck Sharp & Dome |
|
|
|
Consulting or Advisory Role - Merck Serono |
Speakers' Bureau - Merck Serono |
Research Funding - Merck Serono |
Expert Testimony - Merck Serono |
Travel, Accommodations, Expenses - Merck Serono |
|
|
|
Research Funding - Bristol-Myers Squibb (Inst) |
Travel, Accommodations, Expenses - Cochlear; Medel |